Literature DB >> 8304963

Changes in nuclear chromatin precede internucleosomal DNA cleavage in the induction of apoptosis by etoposide.

X M Sun1, R T Snowden, D Dinsdale, M G Ormerod, G M Cohen.   

Abstract

Etoposide, a DNA topoisomerase II inhibitor, caused a concentration-dependent induction of apoptosis in immature thymocytes. Using a flow cytometric method to separate and quantify normal and apoptotic cells, etoposide-induced apoptosis was inhibited by cycloheximide and actinomycin D but not by zinc. Etoposide induced a marked cleavage of DNA into nucleosomal length fragments or multiples thereof, which was completely inhibited if the thymocytes were also incubated in the presence of zinc. Etoposide, alone, induced the classical ultrastructural features of apoptosis, but in the presence of zinc, the morphological pattern was markedly different and dominated by discrete clumps of condensed chromatin abutting the nuclear membrane. These latter changes resemble those described as the earliest changes in apoptosis. These results support the hypothesis that, in the induction of apoptosis, critical alterations in nuclear chromatin occur prior to endonuclease cleavage of DNA into nucleosomal fragments.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8304963     DOI: 10.1016/0006-2952(94)90005-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Chromatin condensation during apoptosis requires ATP.

Authors:  G E Kass; J E Eriksson; M Weis; S Orrenius; S C Chow
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

Review 2.  H2O2-induced higher order chromatin degradation: a novel mechanism of oxidative genotoxicity.

Authors:  Gregory W Konat
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

3.  The novel SAR-binding domain of scaffold attachment factor A (SAF-A) is a target in apoptotic nuclear breakdown.

Authors:  F Göhring; B L Schwab; P Nicotera; M Leist; F O Fackelmayer
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

4.  Induction of apoptosis in human cancer cell lines by the novel anthracenyl-amino acid topoisomerase I inhibitor NU/ICRF 505.

Authors:  I Meikle; J Cummings; J S Macpherson; J F Smyth
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

5.  In situ end-labelling, light microscopic assessment and ultrastructure of apoptosis in lung carcinoma.

Authors:  E F Gaffney; A J O'Neill; M J Staunton
Journal:  J Clin Pathol       Date:  1995-11       Impact factor: 3.411

Review 6.  Higher order chromatin degradation: implications for neurodegeneration.

Authors:  Gregory W Konat
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

7.  Induction of Apoptosis in Rat Peripheral Blood Lymphocytes by the Anticancer Drug CI-994 (Acetyldinaline)(*).

Authors:  Michael J. Graziano; Teresa A. Spoon; Erin A. Cockrell; Paul E. Rowse; Andrea J. Gonzales
Journal:  J Biomed Biotechnol       Date:  2001

8.  Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells.

Authors:  M G Côme; A Skladanowski; A K Larsen; G Laurent
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.